HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
What is the ticker symbol for HilleVax, Inc.? What does HLVX stand for in stocks?
HLVX is the stock ticker symbol of HilleVax, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of HilleVax, Inc. (HLVX)?
As of Wed Nov 20 2024, market cap of HilleVax, Inc. is 89.15 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of HLVX stock?
You can check HLVX's fair value in chart for subscribers.
Is HilleVax, Inc. a good stock to buy?
The fair value guage provides a quick view whether HLVX is over valued or under valued. Whether HilleVax, Inc. is cheap or expensive depends on the assumptions which impact HilleVax, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HLVX.
What is 5 year return on HilleVax, Inc.'s stock?
In the past 10 years, HilleVax, Inc. has provided -0.299 (multiply by 100 for percentage) rate of return.